Can the WATCHMAN device truly PROTECT from stroke in atrial fibrillation?

The Lancet Neurology

Volumn 8, Issue 10, 2009, Pages 877-878

  Wrigley, Benjamin J ^a   Lip, Gregory YH ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NITINOL; WARFARIN;

ANTICOAGULANT THERAPY; ARTIFICIAL EMBOLISM; BLEEDING; CEREBROVASCULAR ACCIDENT; DEVICE; DRUG EFFICACY; DRUG WITHDRAWAL; FALLING; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART TAMPONADE; HUMAN; LETTER; LONG TERM CARE; MONOTHERAPY; NEUROPROTECTION; NONHUMAN; PERCUTANEOUS LEFT ATRIAL APPENDAGE TRANSCATHETER OCCLUSION DEVICE; PRIORITY JOURNAL; SIDE EFFECT; STROKE; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TREATMENT DURATION;

ANIMALS; ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; MULTICENTER STUDIES AS TOPIC; PROSTHESES AND IMPLANTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; WARFARIN;

EID: 69749119497     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70244-3     Document Type: Letter

References (10)

1. Lip G., and Lim H.S. Atrial fibrillation and stroke prevention. Lancet Neurol 6 (2007) 981-993
2. Onalan O., Lashevsky I., Hamad A., and Crystal E. Nonpharmalogical stroke prevention in atrial fibrillation. Exp Rev Cardiovasc Ther 3 (2005) 619-633
3. Hwang J.J., Ko F.N., Li Y.H., et al. Clinical implications and factors related to left atrial spontaneous echo contrast in chronic nonvalvular atrial fibrillation. Cardiology 85 (1994) 69-75
4. Block P.C., Burstein S., Casale P.N., et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv 2 (2009) 594-600
5. Sick P.B., Schuler G., Hauptmann K.E., et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 49 (2007) 1490-1495
6. Holmes D.R., Reddy V.Y., Turi Z.G., et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374 (2009) 534-542
7. Maisel W.H. Left atrial appendage occlusion-closure or just the beginning?. N Engl J Med 360 (2009) 2601-2603
8. Hughes M., Lip G.Y., Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, and National Institute for Health and Clinical Excellence. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost 99 (2008) 295-304
9. Palareti G., and Cosmi B. Bleeding with anticoagulation therapy-who is at risk, and how best to identify such patients. Thromb Haemost 102 (2009) 268-278
10. Lip GYH, Nieuwlaat R, Pisters R, Lane D, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: the Euro Heart Survey on Atrial Fibrillation. Chest (in press).